vela

Claim

Evaluation of 18F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease. — PurposeThe BACE inhibitor verubecestat was previously found to reduce amyloid load as assessed by 18F-flutemetamol positron emission tomography (PET) composite cortical...

Sur C et al. 2022, Molecular imaging and biology

← frontier · vf_7aaa7a87ea99e9e6
Confidence high · 0.63
Evidence experimental
Conditions human
Created 2026-05-06

Evidence span

Evaluation of 18F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease. — PurposeThe BACE inhibitor verubecestat was previously found to reduce amyloid load as assessed by 18F-flutemetamol positron emission tomography (PET) composite cortical...

From Sur C et al. 2022, Molecular imaging and biology

Method & conditions

Evidence type
experimental
Method
manual state transition; control details require source inspection
Species
Homo sapiens
Conditions
Brain; Humans; Alzheimer Disease; Amyloidosis; Aniline Compounds — Molecular imaging and biology 2022
Replicated
not yet

Confidence basis

operator-supplied frontier prior; review required